Paul Castella
Founder at Aeon Bioscience, Inc.
Profile
Paul Castella is the founder of Bio2 Medical, Inc. (founded in 2006) where he holds the title of Director.
He is also the founder of ViroXis Corp.
(founded in 2006) and Aeon Bioscience, Inc. (founded in 2007) where he holds the titles of Director and Chief Business Officer respectively.
In 2020, he founded Hera Biotech, Inc. where he currently serves as Chairman.
Dr. Castella is also the founder of Targeted Technology Ventures LLC.
Currently, Dr. Castella holds positions as Chairman at BioDtech, Inc., Director at StemBioSys, Inc., Director at Innovative Trauma Care, Inc., Director at CytoBioscience, Inc., and Senior Managing Partner at Incyte Venture Partners LLC (since 2013).
Dr. Castella's former positions include Chief Executive Officer & Director at InventaBiotech, Inc. and President & Chief Financial Officer at CardioSpectra, Inc.Dr. Castella's education includes an undergraduate degree from the University of London (1987), an MBA from The University of Texas at Austin (2005), and a doctorate from Weill Cornell Medical College.
Paul Castella active positions
| Companies | Position | Start |
|---|---|---|
Aeon Bioscience, Inc.
 Aeon Bioscience, Inc. Medical SpecialtiesHealth Technology Aeon Bioscience, Inc. develops drug-eluting polymers and stents that overcome concerns of late stent thrombosis. It addresses the medical challenges for cardiac patients. The company was founded by Christopher E. Banas and Paul Castella on January 29, 2007 and is headquartered in Birmingham, AL. | Founder | 07/04/2011 |
Incyte Venture Partners LLC
 Incyte Venture Partners LLC Investment ManagersFinance Incyte Venture Partners LLC (Incyte Venture Partners) is a venture capital firm founded in 2009. The firm is headquartered in San Antonio, Texas. | President | 20/08/2013 |
Bio2 Medical, Inc.
 Bio2 Medical, Inc. Pharmaceuticals: MajorHealth Technology BiO2 Medical, Inc. engages in the design, development, and manufacturing of clinical products. The company was founded by Luis F. Angel, Christopher E. Banas, and Paul Castella in December 2006 and is headquartered in Golden, CO. | Founder | 30/11/2006 |
StemBioSys, Inc.
 StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | Director/Board Member | - |
BioDtech, Inc.
 BioDtech, Inc. BiotechnologyHealth Technology BioDtech, Inc. enagages in the development and marketing of products for the detection, neutralization, and removal of endotoxin. It serves the bioresearch and bioprocess markets. The company was founded by Ira Weiss and Michael G. Pepe in September 2003 and is headquartered in Birmingham, AL. | Chairman | - |
Innovative Trauma Care, Inc.
 Innovative Trauma Care, Inc. Medical SpecialtiesHealth Technology Innovative Trauma Care, Inc. develops and markets medical devices for traumatic injuries. It is an early stage medical device company focused on developing and marketing solutions to address the common causes of preventable death in traumatic injury scenarios. The firm's product iTClamp Hemorrhage Control System is a temporary wound closure device to control severe bleeding within seconds of application to a penetrating injury. Its product iTClamp seals the edges of a wound closed to create a temporary pool of blood under pressure, which forms a stable clot that mitigates further blood loss until the wound can be surgically repaired. The company was founded by Ian Joseph Atkinson and Dennis Frank Filips in 2010 and is headquartered in San Antonio, TX. | Director/Board Member | - |
CytoBioscience, Inc.
 CytoBioscience, Inc. Medical SpecialtiesHealth Technology CytoBioscience, Inc. manufactures medical devices. It creates and manufactures devices that represent a convergence of bioscience, nano science, microchip development, algorithms and engineering. The firm offers CRO services. The company is headquartered in San Antonio, TX. | Director/Board Member | - |
Hera Biotech, Inc.
 Hera Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Hera Biotech, Inc. is a women's health company based in San Antonio, TX. Hera Biotech is focused on transforming women's health with its revolutionary non-surgical test for early diagnosis and staging of endometriosis, called MetriDx™. The company was founded in 2020 by Paul Castella, Bruce Nicholson, Nameer Kirma, and Somer Baburek, who has been the CEO since incorporation. | Founder | 31/12/2019 |
Former positions of Paul Castella
| Companies | Position | End |
|---|---|---|
| INVENTABIOTECH INC. | Chief Executive Officer | - |
| ░░░░░░░ ░░░░░ | ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ | - |
| ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
Training of Paul Castella
| The University of Texas at Austin | Masters Business Admin |
| University of London | Undergraduate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
CardioSpectra, Inc.
 CardioSpectra, Inc. Medical SpecialtiesHealth Technology CardioSpectra, Inc. manufactures and supplies medical devices. The company specializes in optical imaging, interventional cardiology, medical devices and materials science.It develops products for detection of vulnerable plaque, glaucoma, macular degeneration, diabetic retinopathy and cancer. CardioSpectra was founded by Marc D. Feldman & Thomas Milner in 2005 and is headquartered in San Antonio, TX. | Health Technology |
Aeon Bioscience, Inc.
Aeon Bioscience, Inc. Medical SpecialtiesHealth Technology Aeon Bioscience, Inc. develops drug-eluting polymers and stents that overcome concerns of late stent thrombosis. It addresses the medical challenges for cardiac patients. The company was founded by Christopher E. Banas and Paul Castella on January 29, 2007 and is headquartered in Birmingham, AL. | Health Technology |
Incyte Venture Partners LLC
Incyte Venture Partners LLC Investment ManagersFinance Incyte Venture Partners LLC (Incyte Venture Partners) is a venture capital firm founded in 2009. The firm is headquartered in San Antonio, Texas. | Finance |
ViroXis Corp.
 ViroXis Corp. BiotechnologyHealth Technology ViroXis Corp. develops and commercializes bio-pharmaceuticals derived from sandalwood oils for viral diseases. The company was founded in 2006 by Ian William David Clements and Paul Castella and is headquartered in San Antonio, TX. | Health Technology |
Targeted Technology Ventures LLC
 Targeted Technology Ventures LLC Miscellaneous Commercial ServicesCommercial Services Targeted Technology Ventures LLC operated as a biotechnology company. The company was founded by Paul Castella and Christopher E Banas and was headquartered in San Antonio, TX. | Commercial Services |
Bio2 Medical, Inc.
Bio2 Medical, Inc. Pharmaceuticals: MajorHealth Technology BiO2 Medical, Inc. engages in the design, development, and manufacturing of clinical products. The company was founded by Luis F. Angel, Christopher E. Banas, and Paul Castella in December 2006 and is headquartered in Golden, CO. | Health Technology |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | Health Technology |
BioDtech, Inc.
BioDtech, Inc. BiotechnologyHealth Technology BioDtech, Inc. enagages in the development and marketing of products for the detection, neutralization, and removal of endotoxin. It serves the bioresearch and bioprocess markets. The company was founded by Ira Weiss and Michael G. Pepe in September 2003 and is headquartered in Birmingham, AL. | Health Technology |
Innovative Trauma Care, Inc.
Innovative Trauma Care, Inc. Medical SpecialtiesHealth Technology Innovative Trauma Care, Inc. develops and markets medical devices for traumatic injuries. It is an early stage medical device company focused on developing and marketing solutions to address the common causes of preventable death in traumatic injury scenarios. The firm's product iTClamp Hemorrhage Control System is a temporary wound closure device to control severe bleeding within seconds of application to a penetrating injury. Its product iTClamp seals the edges of a wound closed to create a temporary pool of blood under pressure, which forms a stable clot that mitigates further blood loss until the wound can be surgically repaired. The company was founded by Ian Joseph Atkinson and Dennis Frank Filips in 2010 and is headquartered in San Antonio, TX. | Health Technology |
CytoBioscience, Inc.
CytoBioscience, Inc. Medical SpecialtiesHealth Technology CytoBioscience, Inc. manufactures medical devices. It creates and manufactures devices that represent a convergence of bioscience, nano science, microchip development, algorithms and engineering. The firm offers CRO services. The company is headquartered in San Antonio, TX. | Health Technology |
InventaBiotech, Inc.
 InventaBiotech, Inc. Miscellaneous Commercial ServicesCommercial Services InventaBiotech, Inc. operated as a marketing, media, and investor relations consultant to public and private companies. The company was founded on October 18, 2007 and was headquartered in San Antonio, TX. | Commercial Services |
Hera Biotech, Inc.
Hera Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Hera Biotech, Inc. is a women's health company based in San Antonio, TX. Hera Biotech is focused on transforming women's health with its revolutionary non-surgical test for early diagnosis and staging of endometriosis, called MetriDx™. The company was founded in 2020 by Paul Castella, Bruce Nicholson, Nameer Kirma, and Somer Baburek, who has been the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Paul Castella
